Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA grants IND clearance for phase II trial of Aeterna Zentaris' AEZS-108 in breast cancer

Oct. 26, 2011

Bayer's phase III CORRECT trial meets primary endpoint

Oct. 26, 2011

CDC advisory committee recommends Merck & Co.'s HPV vaccine for boys and young men

Oct. 26, 2011

California Stem Cell acquires stem cell therapy program for metastatic melanoma

Oct. 26, 2011

Novel omega-3 MUFAs show oncolytic potential

Oct. 26, 2011

Phase III trial of cabozantinib meets primary endpoint

Oct. 26, 2011

Phase II studies assess NGR-hTNF in lung and ovarian cancer

Oct. 26, 2011

MolMed expands phase III trial of NGR-hTNF

Oct. 25, 2011

Study establishes hENT1 cutoff level for LEAP trial

Oct. 25, 2011

Cell Therapeutics resubmits pixantrone NDA

Oct. 25, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...